Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A pilot study of the Spanish Ketogenic Mediterranean Diet: an effective therapy for the metabolic syndrome.

Pérez-Guisado J, Muñoz-Serrano A.

J Med Food. 2011 Jul-Aug;14(7-8):681-7. doi: 10.1089/jmf.2010.0137. Epub 2011 May 25.

PMID:
21612461
2.

The effect of the Spanish Ketogenic Mediterranean Diet on nonalcoholic fatty liver disease: a pilot study.

Pérez-Guisado J, Muñoz-Serrano A.

J Med Food. 2011 Jul-Aug;14(7-8):677-80. doi: 10.1089/jmf.2011.0075. Epub 2011 Jun 20.

PMID:
21688989
3.

Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss.

Pérez-Guisado J, Muñoz-Serrano A, Alonso-Moraga A.

Nutr J. 2008 Oct 26;7:30. doi: 10.1186/1475-2891-7-30.

4.

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.

Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L.

Metabolism. 2003 Jul;52(7):908-15.

PMID:
12870169
5.

Effects of obesity surgery on the metabolic syndrome.

Lee WJ, Huang MT, Wang W, Lin CM, Chen TC, Lai IR.

Arch Surg. 2004 Oct;139(10):1088-92.

PMID:
15492149
6.

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID:
16861090
7.

Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.

Hunninghake DB, Ballantyne CM, Maccubbin DL, Shah AK, Gumbiner B, Mitchel YB.

Clin Ther. 2003 Jun;25(6):1670-86.

PMID:
12860491
8.

Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.

Tzotzas T, Samara M, Constantinidis T, Tziomalos K, Krassas G.

Angiology. 2007 Feb-Mar;58(1):26-33.

PMID:
17351155
9.

Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.

Mancia G, Bombelli M, Facchetti R, Casati A, Ronchi I, Quarti-Trevano F, Arenare F, Grassi G, Sega R.

J Hypertens. 2010 May;28(5):999-1006. doi: 10.1097/HJH.0b013e328337a9e3.

PMID:
20308922
10.

Cholesteryl ester transfer protein in metabolic syndrome.

Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, Patsch JR, Ebenbichler CF.

Obesity (Silver Spring). 2006 May;14(5):812-8.

11.

Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome.

Ballantyne CM, Stein EA, Paoletti R, Southworth H, Blasetto JW.

Am J Cardiol. 2003 Mar 6;91(5A):25C-27C; discussion 28C.

PMID:
12646342
12.

Measures of obesity and metabolic syndrome in Indian Americans in northern California.

Misra KB, Endemann SW, Ayer M.

Ethn Dis. 2006 Spring;16(2):331-7.

PMID:
17682232
13.

A randomized controlled trial of therapeutic lifestyle modification in rural women with metabolic syndrome: a pilot study.

Oh EG, Hyun SS, Kim SH, Bang SY, Chu SH, Jeon JY, Kang MS.

Metabolism. 2008 Feb;57(2):255-61. doi: 10.1016/j.metabol.2007.09.009.

PMID:
18191057
14.

Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.

Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C.

Metab Syndr Relat Disord. 2009 Oct;7(5):427-34. doi: 10.1089/met.2008.0068.

PMID:
19754305
15.

Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.

Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD.

Asia Pac J Clin Nutr. 2003;12(3):271-6.

16.

Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children.

Chen AK, Roberts CK, Barnard RJ.

Metabolism. 2006 Jul;55(7):871-8.

PMID:
16784957
17.

Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.

de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R.

Clin Nutr. 2006 Feb;25(1):117-22. Epub 2005 Nov 8.

PMID:
16278036
18.

Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

Metabolism. 2005 Apr;54(4):476-81.

PMID:
15798954
19.

Prevalence of metabolic syndrome in an Indian urban population.

Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K.

Int J Cardiol. 2004 Nov;97(2):257-61.

PMID:
15458693
20.

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study.

Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS.

Curr Med Res Opin. 2005 Dec;21(12):1997-2006.

PMID:
16368051

Supplemental Content

Support Center